Regulatory	O
variation	O
in	O
a	O
TBX5	S-GENE
enhancer	O
leads	O
to	O
isolated	O
congenital	O
heart	O
disease	O
.	O


Recent	O
studies	O
have	O
identified	O
the	O
genetic	O
underpinnings	O
of	O
a	O
growing	O
number	O
of	O
diseases	O
through	O
targeted	O
exome	O
sequencing	O
.	O


However	O
,	O
this	O
strategy	O
ignores	O
the	O
large	O
component	O
of	O
the	O
genome	O
that	O
does	O
not	O
code	O
for	O
proteins	O
,	O
but	O
is	O
nonetheless	O
biologically	O
functional	O
.	O


To	O
address	O
the	O
possible	O
involvement	O
of	O
regulatory	O
variation	O
in	O
congenital	O
heart	O
diseases	O
(	O
CHDs	O
)	O
,	O
we	O
searched	O
for	O
regulatory	O
mutations	O
impacting	O
the	O
activity	O
of	O
TBX5	S-GENE
,	O
a	O
dosage	O
-	O
dependent	O
transcription	O
factor	O
with	O
well	O
-	O
defined	O
roles	O
in	O
the	O
heart	O
and	O
limb	O
development	O
that	O
has	O
been	O
associated	O
with	O
the	O
Holt	O
-	O
Oram	O
syndrome	O
(	O
heart	O
-	O
hand	O
syndrome	O
)	O
,	O
a	O
condition	O
that	O
affects	O
1	O
/	O
100	O
000	O
newborns	O
.	O


Using	O
a	O
combination	O
of	O
genomics	O
,	O
bioinformatics	O
and	O
mouse	O
genetic	O
engineering	O
,	O
we	O
scanned	O
~	O
700	O
kb	O
of	O
the	O
TBX5	S-GENE
locus	O
in	O
search	O
of	O
cis	O
-	O
regulatory	O
elements	O
.	O


We	O
uncovered	O
three	O
enhancers	O
that	O
collectively	O
recapitulate	O
the	O
endogenous	O
expression	O
pattern	O
of	O
TBX5	S-GENE
in	O
the	O
developing	O
heart	O
.	O


We	O
re	O
-	O
sequenced	O
these	O
enhancer	O
elements	O
in	O
a	O
cohort	O
of	O
non	O
-	O
syndromic	O
patients	O
with	O
isolated	O
atrial	O
and	O
/	O
or	O
ventricular	O
septal	O
defects	O
,	O
the	O
predominant	O
cardiac	O
defects	O
of	O
the	O
Holt	O
-	O
Oram	O
syndrome	O
,	O
and	O
identified	O
a	O
patient	O
with	O
a	O
homozygous	O
mutation	O
in	O
an	O
enhancer	O
~	O
90	O
kb	O
downstream	O
of	O
TBX5	S-GENE
.	O


Notably	O
,	O
we	O
demonstrate	O
that	O
this	O
single	O
-	O
base	O
-	O
pair	O
mutation	O
abrogates	O
the	O
ability	O
of	O
the	O
enhancer	O
to	O
drive	O
expression	O
within	O
the	O
heart	O
in	O
vivo	O
using	O
both	O
mouse	O
and	O
zebrafish	O
transgenic	O
models	O
.	O


Given	O
the	O
population	O
-	O
wide	O
frequency	O
of	O
this	O
variant	O
,	O
we	O
estimate	O
that	O
1	O
/	O
100	O
000	O
individuals	O
would	O
be	O
homozygous	O
for	O
this	O
variant	O
,	O
highlighting	O
that	O
a	O
significant	O
number	O
of	O
CHD	O
associated	O
with	O
TBX5	S-GENE
dysfunction	O
might	O
arise	O
from	O
non	O
-	O
coding	O
mutations	O
in	O
TBX5	S-GENE
heart	O
enhancers	O
,	O
effectively	O
decoupling	O
the	O
heart	O
and	O
hand	O
phenotypes	O
of	O
the	O
Holt	O
-	O
Oram	O
syndrome	O
.	O
